Treatment of Anxiety/Depression and Pain Through Relaxation Yoga for Patient With Cystic Fibrosis (CF)
NCT ID: NCT01180842
Last Updated: 2014-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
20 participants
INTERVENTIONAL
2010-03-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is a pre/post-test study with 20 subjects. The subjects will serve as their own controls. Each subject will participate in six yoga sessions over a ten week period. Subjects' symptoms will be evaluated with the use of questionnaires. The investigators will also test cortisol levels on weeks -2, -1, 1, 6, 7, 8. Cortisol is a hormone that is affected by stress. Testing of cortisol throughout the study will help us determine the subjects' stress level throughout the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Yoga as a Therapy for Cystic Fibrosis (CF) Patients
NCT01325766
Pilot Study of a CF-specific CBT Intervention for Adolescents
NCT05271643
YOGA-CF (Yoga Outcomes Get Assessed in Cystic Fibrosis)
NCT06120465
Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients
NCT01822197
Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis
NCT00577252
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
H2: The implementation of a yoga therapy program decreases symptoms of sleep disturbance within our CF population.
H3: The implementation of a yoga therapy program decreases symptoms of anxiety within our CF population.
H4: The implementation of a yoga therapy program decreases symptoms of depression within our CF population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Alternative Treatment
The CF Patient Population receiving the specific yoga study treatment
Yoga treatment program
yoga program designed specifically for the patient with CF
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Yoga treatment program
yoga program designed specifically for the patient with CF
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Males or females within the ages of 9 and 18
Exclusion Criteria
* Younger than 9 years of age or older than 18 years of age
* Concomitant illness or disease that may inhibit the patient's ability to participate in the study as determined by the principal investigator
* The patient has participated in an investigational treatment study 30 days prior to pre-session week -2.
* The patient is currently participating in yoga sessions one or more times per week.
9 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospitals and Clinics of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John McNamara, MD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospitals and Clinics of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospitals and Clinics of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0911-104
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.